12/5
11:33 am
nvo
Hims and Hers acquires Livewell ahead of generic Ozempic launch in Canada [Yahoo! Finance Canada]
Low
Report
Hims and Hers acquires Livewell ahead of generic Ozempic launch in Canada [Yahoo! Finance Canada]
12/5
06:30 am
nvo
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
12/5
05:52 am
nvo
Update: Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide [Yahoo! Finance]
Low
Report
Update: Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide [Yahoo! Finance]
12/4
11:58 am
nvo
Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer's, despite trial setback [MSNBC.com]
Low
Report
Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer's, despite trial setback [MSNBC.com]
12/4
10:58 am
nvo
Novo Nordisk A/S (NVO): A Bull Case Theory [Yahoo! Finance]
Low
Report
Novo Nordisk A/S (NVO): A Bull Case Theory [Yahoo! Finance]
12/4
09:00 am
nvo
4 stocks to watch on Thursday: NVO, PLTR, DG, PSKY [Seeking Alpha]
Low
Report
4 stocks to watch on Thursday: NVO, PLTR, DG, PSKY [Seeking Alpha]
12/4
06:34 am
nvo
Alzheimer's Clinical Trial Results, Sadly Running True To Form [Seeking Alpha]
Low
Report
Alzheimer's Clinical Trial Results, Sadly Running True To Form [Seeking Alpha]
12/3
09:58 pm
nvo
Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback [MSNBC.com]
Low
Report
Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback [MSNBC.com]
12/3
02:32 pm
nvo
Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight [Yahoo! Finance]
Low
Report
Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight [Yahoo! Finance]
12/3
01:42 pm
nvo
Novo Nordisk gears up for December Ozempic launch in India, sources say [Yahoo! Finance]
Low
Report
Novo Nordisk gears up for December Ozempic launch in India, sources say [Yahoo! Finance]
12/3
07:19 am
nvo
Novo Nordisk A/S (NYSE:NVO) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Novo Nordisk A/S (NYSE:NVO) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
12/3
06:19 am
nvo
UK Agrees To Pay More For US Medicines After Trade Negotiations [zero hedge]
Low
Report
UK Agrees To Pay More For US Medicines After Trade Negotiations [zero hedge]
12/2
02:23 pm
nvo
Here's Why Novo Nordisk Just Paid $2.1 Billion For Zaltenibart [Seeking Alpha]
Low
Report
Here's Why Novo Nordisk Just Paid $2.1 Billion For Zaltenibart [Seeking Alpha]
12/1
06:20 pm
nvo
Canada's public drug plans, Novo Nordisk end talks to cover Wegovy [Globe and Mail, The (Toronto, Canada)]
Low
Report
Canada's public drug plans, Novo Nordisk end talks to cover Wegovy [Globe and Mail, The (Toronto, Canada)]
12/1
12:22 pm
nvo
European Association for the Study of Diabetes (EASD) Annual Meeting Highlights 2025: Advancements in GLP-1RAs for Diabetes, Cardiovascular Treatments, and Therapies for Resistant Hypertension [Yahoo! Finance]
Low
Report
European Association for the Study of Diabetes (EASD) Annual Meeting Highlights 2025: Advancements in GLP-1RAs for Diabetes, Cardiovascular Treatments, and Therapies for Resistant Hypertension [Yahoo! Finance]
12/1
10:04 am
nvo
WHO backs use of GLP-1 therapies for obesity, warns access will remain limited [CNBC]
Low
Report
WHO backs use of GLP-1 therapies for obesity, warns access will remain limited [CNBC]
12/1
10:04 am
nvo
Eli Lilly slashes obesity drug price by up to 20% [Los Angeles Times (CA)]
Low
Report
Eli Lilly slashes obesity drug price by up to 20% [Los Angeles Times (CA)]
12/1
09:20 am
nvo
World Health Organization recommends GLP-1s for obesity. There's a catch. [USA TODAY]
Low
Report
World Health Organization recommends GLP-1s for obesity. There's a catch. [USA TODAY]
12/1
07:52 am
nvo
Medicare Reveals 44% Lower Prices For 15 Drugs In 2nd Round Of Negotiations [Forbes]
Low
Report
Medicare Reveals 44% Lower Prices For 15 Drugs In 2nd Round Of Negotiations [Forbes]
12/1
07:35 am
nvo
Top 10 Healthcare Industry Predictions For 2026 [Forbes]
Low
Report
Top 10 Healthcare Industry Predictions For 2026 [Forbes]
11/30
06:17 am
nvo
Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters [Seeking Alpha]
Low
Report
Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters [Seeking Alpha]
11/29
12:16 pm
nvo
Trending stocks amid Wall Street rally this week [Seeking Alpha]
Low
Report
Trending stocks amid Wall Street rally this week [Seeking Alpha]
11/28
10:35 pm
nvo
Novo Nordisk: Headwinds On The Surface, Deep Value If You Dig [Seeking Alpha]
Low
Report
Novo Nordisk: Headwinds On The Surface, Deep Value If You Dig [Seeking Alpha]
11/28
05:53 pm
nvo
Novo Nordisk: A Textbook Value Trap [Seeking Alpha]
Low
Report
Novo Nordisk: A Textbook Value Trap [Seeking Alpha]
11/28
08:43 am
nvo
Novo Nordisk A/S (NYSE:NVO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $60.00 to $54.00. They now have a "buy" rating on the stock.
Low
Report
Novo Nordisk A/S (NYSE:NVO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $60.00 to $54.00. They now have a "buy" rating on the stock.